Literature DB >> 26310185

Risks and predictors of mild diastolic dysfunction among middle-aged and aged women: a population-based cohort study.

J Wu1,2, S Y Yu1, D Wo1, M M Zhao1, L J Zhang1, J Li1,2.   

Abstract

We sought to determine the predictors of primary episodes of mild diastolic dysfunction (DD) in a cohort of women aged >45 years, who had >2 echocardiography from 2009 to 2012. Patients were excluded if they had prior diagnosis of coronary artery disease, heart failure, valvular heart disease or echocardiographic evidence of DD. Mild DD was defined as: left ventricular ejection fraction>50%, E/A ratio<0.75, and E/e'⩽8. Out of the total 758 subjects (age 64.15±7.24 years), 109 (14.3%) had developed mild DD, during a mean followup period of 3 years. Independent predictors of mild DD included: age (P<0.001), history of hypertension (P=0.022), body mass index (BMI) (P<0.001), total triglycerides (TG) (P=0.016), inter ventricular septal thickness (P=0.015) and brachial-ankle pulse wave velocity (baPWV) ⩾16 m s(-1) (P<0.001). E/A ratio was inversely associated with age (r=-0.337, P<0.001), baPWV (r=-0.359, P<0.001), BMI (r=-0.290, P<0.001) and TG (r=-0.255, P<0.001). The Area Under roc Curve for a linear combination of age, BMI, baPWV and TG was 0.738 (95% confidence interval: 0.683-0.804, P<0.001), which was superior to any of the variables taken alone. In summary, many middle-aged or elderly women may develop mild DD within a relatively short period of 3 years. Several subclinical abnormalities and cardiovascular parameters were determined to contribute to the onset of DD.

Entities:  

Mesh:

Year:  2015        PMID: 26310185     DOI: 10.1038/jhh.2015.85

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

1.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

2.  Plasma triglyceride level is an independent predictor of altered left ventricular relaxation.

Authors:  Lisa de las Fuentes; Alan D Waggoner; Angela L Brown; Víctor G Dávila-Román
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

3.  Progression of left ventricular diastolic dysfunction and risk of heart failure.

Authors:  Garvan C Kane; Barry L Karon; Douglas W Mahoney; Margaret M Redfield; Veronique L Roger; John C Burnett; Steven J Jacobsen; Richard J Rodeheffer
Journal:  JAMA       Date:  2011-08-24       Impact factor: 56.272

4.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.

Authors:  Mikko Kankaanpää; Hanna-Riikka Lehto; Jussi P Pärkkä; Markku Komu; Antti Viljanen; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila; Riitta Parkkola; Patricia Iozzo
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

5.  Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.

Authors:  Miho Kawaguchi; Ilan Hay; Barry Fetics; David A Kass
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

6.  Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey.

Authors:  W P Abhayaratna; T H Marwick; W T Smith; N G Becker
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

Review 7.  Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old.

Authors:  D W Kitzman; D G Scholz; P T Hagen; D M Ilstrup; W D Edwards
Journal:  Mayo Clin Proc       Date:  1988-02       Impact factor: 7.616

8.  Interventricular septum thickness predicts future systolic hypertension in young healthy pilots.

Authors:  Chagai Grossman; Alon Grossman; Nira Koren-Morag; Bella Azaria; Liav Goldstein; Ehud Grossman
Journal:  Hypertens Res       Date:  2008-01       Impact factor: 3.872

Review 9.  Left ventricular diastolic dysfunction and diastolic heart failure.

Authors:  William H Gaasch; Michael R Zile
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

Review 10.  A practical approach to the echocardiographic evaluation of diastolic function.

Authors:  Samer J Khouri; George T Maly; David D Suh; Thomas E Walsh
Journal:  J Am Soc Echocardiogr       Date:  2004-03       Impact factor: 5.251

View more
  4 in total

1.  Association between cystatin C and heart failure with preserved ejection fraction in elderly Chinese patients.

Authors:  C C Xu; G X Fu; Q Q Liu; Y Zhong
Journal:  Z Gerontol Geriatr       Date:  2016-05-20       Impact factor: 1.281

2.  Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2.

Authors:  Jacqueline S da Silva; Daniele Gabriel-Costa; Hao Wang; Sarfaraz Ahmad; Xuming Sun; Jasmina Varagic; Roberto T Sudo; Carlos M Ferrario; Louis J Dell Italia; Gisele-Zapata Sudo; Leanne Groban
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Jul-Sep       Impact factor: 1.636

3.  Relationship of Noninvasive Assessment of Arterial Stiffness with 10-Year Atherosclerotic Cardiovascular Disease (ASCVD) Risk in a General Middle-Age and Elderly Population.

Authors:  Hao Wang; Xubo Wu; Yefan Gu; Jie Zhou; Jing Wu
Journal:  Int J Gen Med       Date:  2021-10-05

4.  Association between reduced arterial stiffness and preserved diastolic function of the left ventricle in middle-aged and elderly patients.

Authors:  Kyung-Taek Park; Hack-Lyoung Kim; Sohee Oh; Woo-Hyun Lim; Jae-Bin Seo; Woo-Young Chung; Sang-Hyun Kim; Myung-A Kim; Joo-Hee Zo
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-02-13       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.